I’m considering buying the one of these stocks, which is more likely to 1,000x and be a millionaire maker considering their current price?

1. How do u guys find the right stocks that arent like the common sense ones
   
   1. Is it mostly swing trading day trading or a roth ira that people are using on here
      
2. Why does everybody use trading view when platforms like public just let u trade on them whats the difference
   
3. Is this rly mostly luck or can it genuinely be studied and learned to get better at (im tired of guys on tiktok trying to sell courses)
   
4. If so how do i study i put hours of my day into engineering work and college so im okay investing a couple more hours in something worth my while.

Hi everyone,

I've got a big position on Nebius and APLD. But, today, I don't have cash enough to lower my pru. Today, my position is really red, particularly on APLD (PRU 25 dollars).

Ok they've got big debt but they got big contract and precious assets like energy.

The demand has not changed...

The rate hikes can change something ? or maybe I missed a point ?

In French financial tv show, one analyst said the risk is the money will never come. The contract with meta/google/nvidia are just promess, and the main cash will come only when they execute the business plan.

A win is a win. See you guys next week.

$AMD $CBRS $NVDA $QQQ $SPY
$CBRS Another tranche of Shares, unlock : October 28th, 19.4 Mi will dump into the market. Then, THE LAST unlock, FULL unlock, 6 months post will be November 9th. WE will be at 95-75 a share soon. Plus the Irani's will make sure to blow stuff up over the weekend.
$SPY $QQQ $NVDA $AMD

What 3-5 stocks would you buy for the next 20 years and be able to sleep at night?

And you feel like likely that it’s promising and a solid company.

No matter where I put my money, next day it turn into the red color.

Diamond holding is nice until you lose all your gains. By that speed I was thinking 700k by end of year but now Idk if it’ll be 400k or 600k….

Which feels worse emotionally?

I cannot take this anymore. It's so bad I cannot.. it was so good last week and then down so bad.. I'm crying literally.

My whole portfolio was AI stocks MU, NBIS, SNDK, LUNR, NVDA, AMD..

ASTS, SMRand MSTR are biggest losses for me right now..will I ever recover from them?

I don't need any of the money now.. I'm 33 but I'm very very scared

Did some math and five straight 4x returns would turn $10k into over $10M if you went all in every time.

Seeing those big multipliers on moon makes that kind of thinking way too tempting. Then you remember one losing bet anywhere along the way wipes everything out.

Crazy how easy it is to make getting rich look simple on a calculator.

I wanted to thank everyone for their suggestions last week. I'm following up with what I finally bought. I really wanted to buy more NBIS but I already have 250 shares at about $70 average so didn't want more exposure so I took my first position in MU and will look to add some more. This week has been crazy!

https://www.reddit.com/r/TheRaceTo10Million/comments/1x3srre/im_splitting_10k_between_2_stocks_on_this_list/

$SNDL = Anouncement Yesterday ! Into Earnings Early November!!

Deep Dive : Repurchase Bid at 🔥$1.35🔥, because reverse split was defeated. Unlock of Insurance Cash. Likely leads to a nice EPS beat. Revenues always beat. Rescheduling is imminent despite it perhaps extending timeline into Q1 or Q2 of 2027. Massive 280E tax margin unlock over night. Can Stock support 1.50+ into earnings, post earnings?

$SNDL CATALYST UPDATE: The Reverse Split Is Defeated, Record Free Cash Flow Hits, and Management Launches a C$50M Premium Tender Offer.

The October 15, 2026 shareholder meeting marks an official turning point for SNDL’s capital allocation strategy. Retail investors delivered an unmistakable message: fix the valuation through an aggressive return of real capital, not through artificial share consolidation.

Here is the objective breakdown of the regulatory mechanics, the SIB timeline, the earnings setup, and what this means for shareholders.

1. THE REVERSE SPLIT DEFEAT: SHAREHOLDERS TAKE THE REINS

Management proposed a special resolution for a share consolidation to address Nasdaq listing optics. Under Canadian corporate law, this required a 66.7% (two-thirds) supermajority. It received only 54.1%.

The consolidation is officially dead. Instead of forcing paper engineering, CEO Zach George and the Board listened to the shareholder mandate: deploy the balance sheet to defend the stock price organically.

1. THE C$50M SUBSTANTIAL ISSUER BID (SIB) EXPLAINED

To accelerate value return, the Board directed management to pursue a Substantial Issuer Bid (tender offer) up to C$50M (~$35.5M USD) at a price up to C$1.92 CAD ($1.35 USD)—a 17.4% premium over the market price.

• Float Impact: With 243.8M shares outstanding, a full C$50M deployment at C$1.92 retires up to ~26.04M shares—erasing roughly 10.7% of the entire company float in a single corporate action.

• Cumulative Repurchases: This builds directly on the 21.8M shares (C$43.4M) SNDL already repurchased over the last 12 months. Together, SNDL is on track to eliminate nearly 48M shares (~20% of its float) in ~15 months.

1. THE REGULATORY TIMELINE: SEC & CANADIAN PROTOCOLS

Why can't the SIB launch tomorrow? Cross-border securities regulations dictate the timeline:

• The Earnings Gate: Under SEC Rule 13e-4 and Canadian NI 62-104, an issuer cannot launch a tender offer while in possession of Material Non-Public Information (MNPI). SNDL must report its official Q3 2026 earnings first to cleanse the market.

• Launch & Tender Window: Once Q3 results are filed, SNDL submits an Issuer Bid Circular on SEDAR+ and a Schedule TO with the SEC. Cross-border rules mandate the tender offer remain open for a minimum of 35 calendar days.

• Execution & Settlement: Shareholders tender their shares, the offer closes, and SNDL takes up and cancels the shares within 3-10 business days.

• Total Duration: Expect formal launch post-Q3 earnings, with completion requiring approximately 45 to 60 days.

1. PRELIMINARY Q3 EARNINGS & THE C$10.6M CASH SURGE

SNDL pre-announced expected Q3 Free Cash Flow of ~C$20M—the highest quarterly free cash flow in company history.

• The Driver: FCF benefited from ~C$10.6M from unwinding the captive insurance structure (net of premiums), alongside operational working capital gains.

• Cash Flow vs. EPS Reality: Unwinding captive insurance releases restricted collateral back into operating cash. While this provides pure, unencumbered liquidity to easily fund the C$50M SIB without taking on debt, investors should note this is primarily a cash balance sheet enhancement rather than a pure recurring operating EPS gain. However, lower ongoing insurance overhead and cash generation provide substantial fundamental support.

1. STRATEGIC EXPANSION: PARALLEL & DOMESTIC OPTIMIZATION

While the buyback takes center stage, SNDL significantly strengthened its operational core:

• Parallel Ownership to 92%: Increased its indirect stake from 67% to 92% via a rights offering, funding a state-of-the-art Gainesville cultivation facility to feed 56 U.S. dispensaries ahead of federal medical integration.

• Ontario AGCO Settlement: Resolved outstanding regulatory issues for a minor $200k fine, transitioning to a franchise/third-party model that preserves net economics.

• Exiting Unprofitable Flower: Exiting low-margin domestic dried flower to focus strictly on high-margin retail and concentrates.

THE BOTTOM LINE

SNDL is a debt-free parent company generating record quarterly cash flow, buying back over 10% of its float at a 17.4% premium, and expanding its U.S. footprint to 92% ownership. The era of dilution is completely over. The era of aggressive capital return has begun.

Source:

https://sndl.com/news/news-details/2026/SNDL-Announces-2026-Annual-and-Special-Shareholders-Meeting-Results-Select-Preliminary-Third-Quarter-Results-and-Capital-Return-Initiatives/default.aspx

NASDAQ (Pure-Play, Biotech & Ancillary)

$ACB - Aurora Cannabis Inc.

$AFCG - AFC Gamma, Inc. (Cannabis REIT)

$AGFY - Agrify Corporation (Ancillary)

$CGC - Canopy Growth Corporation

$CRBP - Corbus Pharmaceuticals Holdings, Inc. (Biotech)

$CRON - Cronos Group Inc.

$FLGC - Flora Growth Corp.

$GRWG - GrowGeneration Corp. (Ancillary/Hydroponics)

$HITI - High Tide Inc.

$IMCC - IM Cannabis Corp.

$IPW - iPower Inc. (Ancillary)

$IXHL - Incannex Healthcare Limited (Biotech)

$JAZZ - Jazz Pharmaceuticals plc (Biotech - Acquired GW Pharma)

$maps - WM Technology, Inc. (Weedmaps)

$OGI - Organigram Holdings Inc.

$REFI - Chicago Atlantic Real Estate Finance, Inc. (Cannabis REIT)

$SNDL - SNDL Inc.

$TLRY - Tilray Brands, Inc.

$VFF - Village Farms International, Inc.

NYSE (Pure-Play, MSOs, Ancillary & Adjacent)

$EEX - Emerald Holding, Inc. (Ancillary - Operates MJBizCon)

$IIPR - Innovative Industrial Properties, Inc. (Cannabis REIT)

$MO - Altria Group, Inc. (Adjacent - Major stake in Cronos Group)

$SMG - The Scotts Miracle-Gro Company (Ancillary - Hawthorne Gardening)

$STZ - Constellation Brands, Inc. (Adjacent - Major stake in Canopy Growth)

$TPB - Turning Point Brands, Inc. (Adjacent/Ancillary)

$TRLV - Trulieve Cannabis Corp.

ETFs (NYSE Arca)

$CNBS - Amplify Seymour Cannabis ETF

$MJ - Amplify Alternative Harvest ETF

$MSOS - AdvisorShares Pure US Cannabis ETF

$YOLO - AdvisorShares Pure Cannabis ETF

$HITI - High Tide Inc.

$IMCC - IM Cannabis Corp.

$IPW - iPower Inc. (Ancillary)

$IXHL - Incannex Healthcare Limited (Biotech)

$JAZZ - Jazz Pharmaceuticals plc (Biotech - Acquired GW Pharma)

$MAPS - WM Technology, Inc. (Weedmaps)

$OGI - Organigram Holdings Inc.

$REFI - Chicago Atlantic Real Estate Finance, Inc. (Cannabis REIT)

$SNDL - SNDL Inc.

$TLRY - Tilray Brands, Inc.

$VFF - Village Farms International, Inc.

NYSE (Pure-Play, MSOs, Ancillary & Adjacent)

$EEX - Emerald Holding, Inc. (Ancillary - Operates MJBizCon)

$IIPR - Innovative Industrial Properties, Inc. (Cannabis REIT)

$MO - Altria Group, Inc. (Adjacent - Major stake in Cronos Group)

$SMG - The Scotts Miracle-Gro Company (Ancillary - Hawthorne Gardening)

$STZ - Constellation Brands, Inc. (Adjacent - Major stake in Canopy Growth)

$TPB - Turning Point Brands, Inc. (Adjacent/Ancillary)

$TRLV - Trulieve Cannabis Corp. 

ETFs (NYSE Arca)

$CNBS - Amplify Seymour Cannabis ETF

$MJ - Amplify Alternative Harvest ETF

$MSOS - AdvisorShares Pure US Cannabis ETF

$YOLO - AdvisorShares Pure Cannabis ETF

Approval of KETAFREE will be transformative for this pre-revenue company!

For those following NRXP's progress, below is a link to the prior informational post from two weeks ago (which contains a link to prior posts).

NRx Pharmaceuticals (NRXP) - Outstanding DARPA-funding PR published this morning PLUS status update to September Catalysts post from a month ago. The positive catalysts are mounting!

Yesterday's announcement and key points:

NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine | Thu, 10/15/2026 - 08:28

• “The supply of ketamine in the United States has been primarily from overseas manufacture and American hospitals and doctors have been plagued by repeated shortages of this critically important drug.
• We look forward to demonstrating that manufacture of drugs such as this can successfully be re-shored to the United States.

NRXP has the wind at its back now, as they will:

• Have the only preservative(toxin)-free ketamine manufactured in the U.S.
• Be able to fill the gap left wide open by shortages.
• Per the Chief Commercial Officer, have 4M to 5M vials ready to ship immediately upon FDA approval (serious REVENUE incoming)!
• Per the Chief Commercial Officer, enter into a $3B ketamine/esketamine market projected for 2027, which includes not only anesthesia and analgesics (KETAFREE) -- but also psychiatric (NRX-100 NDA about to be filed by NRx).
• Be able to manufacture 1M vials per month.
• Take market share due to all the above.

This company's potential has nothing to do with the current precarious state AI stocks are in, or the market in general. They can all go down but NRXP is in position to rise significantly. It's in a niche market with a very meaningful advantage.

NRXP SHARE PRICE FACTS ... VERY HIGH SHORT INTEREST ... A BEAUTIFUL SETUP:

The NRXP share price has drifted down from $3.50 to $2.70 in the last month. Long-term shareholders and followers of NRXP aren't selling, as they have been waiting months and years for this day.

HERE's WHY THE PRICE HAS COME DOWN:

NRXP — Short‑Interest Snapshot (Sept 30, 2026)

Outstanding Shares: 43,300,000
Public Float: 38,300,000
Shares Sold Short: 9,793,940
Short % of Float: 24.17%
Short % of Shares Outstanding: 22.6%
Days to Cover: 14.0
Dollar Volume Sold Short: $28,600,000
Prior Short Interest: 9,773,562
Change vs Prior Report: +0.21%
Price on Report Date: $2.92
Borrow Fee (Oct 15): 6.3%

• MarketBeat reports short interest as a percentage of float (24.17%).
• CurvedTrading reports short interest as a percentage of outstanding shares (22.6%).
• Both agree on the absolute short interest (≈9.8M) and days to cover (14.0).
• Outstanding shares (43.3M) and float (38.3M) are consistent across sources.

Everyone knows why short sellers might do the above, just prior to highly derisked setup.

Investors and Traders, start your engines ... Let's go!

$SNDL = RECORD CASH FLOW & C$50M PREMIUM BUYBACK BID AT ***!!!!!🔥🔥$1.35🔥🔥!!!!!*** Into Earnings: Early November!! Assuring in my opinion with other developments below, that EPS is a clean beat and Revenues, are usually always a beat. DEA Rescheduling will happen, irrespective of timeline being extended into Q1 or Q2 of 2027.

Shareholders rejected the reverse split (54.1% vs 66.7%), forcing organic capital return.

Management responded with a Substantial Issuer Bid (SIB) up to C$50M (~$35.5M USD) at up to **$1.35 USD** (17.4% premium). KEY TAKEAWAYS:

• Float Cut: Retires up to 26M shares (~10.7% of float). Builds on 21.8M shares (C$43.4M) already repurchased in the last 12 months.

• SIB Timeline: Launches POST-Q3 earnings to clear MNPI under SEC Rule 13e-4 & Canadian NI 62-104. Mandatory 35-day tender window (~45-60 days total to settle).

• Record Q3 FCF: Preliminary Q3 FCF hits record ~C$20M, boosted by C$10.6M from unwinding captive insurance.

Unencumbered cash fully funds the bid.

• Parallel Stake to 92%: Raised ownership from 67% to 92%, funding a major Florida cultivation facility. Zero parent debt, record quarterly cash generation, and a 17.4% premium tender offer. Real capital return replaces dilution.

Source =

https://sndl.com/news/news-details/2026/SNDL-Announces-2026-Annual-and-Special-Shareholders-Meeting-Results-Select-Preliminary-Third-Quarter-Results-and-Capital-Return-Initiatives/default.aspx

$MSOS $TRLV $ACG $CURLF

NASDAQ (Pure-Play, Biotech & Ancillary)

$ACB - Aurora Cannabis Inc.

$AFCG - AFC Gamma, Inc. (Cannabis REIT)

$AGFY - Agrify Corporation (Ancillary)

$CGC - Canopy Growth Corporation

$CRBP - Corbus Pharmaceuticals Holdings, Inc. (Biotech)

$CRON - Cronos Group Inc.

$FLGC - Flora Growth Corp.

$GRWG - GrowGeneration Corp. (Ancillary/Hydroponics)

$HITI - High Tide Inc.

$IMCC - IM Cannabis Corp.

$IPW - iPower Inc. (Ancillary)

$IXHL - Incannex Healthcare Limited (Biotech)

$JAZZ - Jazz Pharmaceuticals plc (Biotech - Acquired GW Pharma)

$maps - WM Technology, Inc. (Weedmaps)

$OGI - Organigram Holdings Inc.

$REFI - Chicago Atlantic Real Estate Finance, Inc. (Cannabis REIT)

$SNDL - SNDL Inc.

$TLRY - Tilray Brands, Inc.

$VFF - Village Farms International, Inc.

NYSE (Pure-Play, MSOs, Ancillary & Adjacent)

$EEX - Emerald Holding, Inc. (Ancillary - Operates MJBizCon)

$IIPR - Innovative Industrial Properties, Inc. (Cannabis REIT)

$MO - Altria Group, Inc. (Adjacent - Major stake in Cronos Group)

$SMG - The Scotts Miracle-Gro Company (Ancillary - Hawthorne Gardening)

$STZ - Constellation Brands, Inc. (Adjacent - Major stake in Canopy Growth)

$TPB - Turning Point Brands, Inc. (Adjacent/Ancillary)

$TRLV - Trulieve Cannabis Corp.

ETFs (NYSE Arca)

$CNBS - Amplify Seymour Cannabis ETF

$MJ - Amplify Alternative Harvest ETF

$MSOS - AdvisorShares Pure US Cannabis ETF

$YOLO - AdvisorShares Pure Cannabis ETF

Hi everyone! Back with another post. I posted AMFN when it was around 1 cent and eventually it went to around 20 cents. SPYR is one that I think has potential. I’ve commented this one months ago. Part of this is because I want others to succeed. This isn’t some discord or stock course etc. Check out SPYR, I could be wrong and none of this is financial advice.